| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.889 | 0.005 | 0.931 | Antiinflammatory | 0.931 0.005 DBMET00589 | DBMET00589 | |
| 0.779 | 0.003 | 0.779 | Cyclooxygenase 1 inhibitor | 0.493 0.005 DBMET00589 | ||
| 0.677 | 0.004 | 0.882 | Non-steroidal antiinflammatory agent | 0.882 0.003 DBMET00589 | DBMET00589 | |
| 0.668 | 0.01 | 0.793 | Cholesterol antagonist | 0.793 0.004 DBMET00589 | DBMET00589 | |
| 0.658 | 0.005 | 0.658 | Superoxide dismutase inhibitor | |||
| 0.64 | 0.014 | 0.64 | Aldehyde oxidase inhibitor | |||
| 0.62 | 0.004 | 0.62 | Amyloid beta precursor protein antagonist | 0.163 0.087 DBMET00589 | ||
| 0.629 | 0.022 | 0.629 | Analgesic | 0.35 0.109 DBMET00589 | ||
| 0.584 | 0.004 | 0.584 | Cyclooxygenase inhibitor | 0.37 0.009 DBMET00589 | ||
| 0.558 | 0.011 | 0.558 | Calcium channel L-type activator | 0.412 0.073 DBMET00589 | ||
| 0.548 | 0.003 | 0.548 | Calcium channel activator | 0.337 0.059 DBMET00589 | ||
| 0.506 | 0.008 | 0.506 | Anesthetic general | 0.434 0.013 DBMET00589 | ||
| 0.482 | 0.014 | 0.482 | Hypolipemic | 0.448 0.018 DBMET00589 | ||
| 0.464 | 0.005 | 0.464 | Interleukin 6 antagonist | 0.284 0.017 DBMET00589 | ||
| 0.501 | 0.05 | 0.759 | Cyclophilin D inhibitor | 0.759 0.009 DBMET00589 | DBMET00589 | |
| 0.479 | 0.032 | 0.703 | Antithrombotic | 0.703 0.008 DBMET00589 | DBMET00589 | |
| 0.486 | 0.046 | 0.844 | Transcription factor NF kappa B inhibitor | 0.844 0.01 DBMET00589 | DBMET00589 | |
| 0.45 | 0.026 | 0.45 | Lipoxygenase inhibitor | |||
| 0.433 | 0.01 | 0.433 | Sodium/bile acid cotransporter inhibitor | 0.417 0.013 DBMET00589 | ||
| 0.447 | 0.025 | 0.447 | Interleukin antagonist | 0.172 0.102 DBMET00589 | ||
| 0.426 | 0.008 | 0.502 | Alpha-N-acetylglucosaminidase inhibitor | 0.502 0.005 DBMET00589 | DBMET00589 | |
| 0.419 | 0.004 | 0.419 | Gastrin inhibitor | 0.308 0.028 DBMET00589 | ||
| 0.419 | 0.022 | 0.538 | Interleukin 2 agonist | 0.538 0.005 DBMET00589 | DBMET00589 | |
| 0.416 | 0.025 | 0.609 | Hypoglycemic | 0.609 0.008 DBMET00589 | DBMET00589 | |
| 0.387 | 0.006 | 0.387 | Interleukin 1 antagonist | 0.183 0.041 DBMET00589 | ||
| 0.382 | 0.006 | 0.382 | Cyclooxygenase 2 inhibitor | 0.245 0.021 DBMET00589 | ||
| 0.431 | 0.06 | 0.487 | Histamine release inhibitor | 0.487 0.033 DBMET00589 | DBMET00589 | |
| 0.369 | 0.004 | 0.369 | Interleukin 8 antagonist | 0.1 0.096 DBMET00589 | ||
| 0.38 | 0.021 | 0.38 | Platelet aggregation inhibitor | |||
| 0.386 | 0.04 | 0.582 | Vasodilator, coronary | 0.582 0.009 DBMET00589 | DBMET00589 | |
| 0.352 | 0.008 | 0.352 | Chelator | 0.119 0.054 DBMET00589 | ||
| 0.371 | 0.03 | 0.371 | Amyloid beta aggregation inhibitor | 0.213 0.071 DBMET00589 | ||
| 0.373 | 0.04 | 0.709 | Antioxidant | 0.709 0.005 DBMET00589 | DBMET00589 | |
| 0.397 | 0.064 | 0.567 | Immunosuppressant | 0.567 0.018 DBMET00589 | DBMET00589 | |
| 0.357 | 0.032 | 0.357 | Insulysin inhibitor | |||
| 0.34 | 0.018 | 0.34 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.343 | 0.031 | 0.478 | Interleukin agonist | 0.478 0.01 DBMET00589 | DBMET00589 | |
| 0.359 | 0.05 | 0.55 | Spasmolytic | 0.55 0.018 DBMET00589 | DBMET00589 | |
| 0.311 | 0.005 | 0.346 | ATPase inhibitor | 0.346 0.004 DBMET00589 | DBMET00589 | |
| 0.322 | 0.02 | 0.339 | Thrombolytic | 0.339 0.018 DBMET00589 | DBMET00589 | |
| 0.301 | 0.004 | 0.301 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.302 | 0.006 | 0.563 | Cyclooxygenase 3 inhibitor | 0.563 0.003 DBMET00589 | DBMET00589 | |
| 0.302 | 0.013 | 0.302 | Phospholipase A2 inhibitor | 0.233 0.028 DBMET00589 | ||
| 0.355 | 0.072 | 0.355 | Thyroid hormone antagonist | |||
| 0.287 | 0.01 | 0.287 | GABA C receptor agonist | |||
| 0.328 | 0.053 | 0.328 | Hypoxia-inducible factor 1 alpha inhibitor | 0.255 0.096 DBMET00589 | ||
| 0.32 | 0.046 | 0.599 | Free radical scavenger | 0.599 0.009 DBMET00589 | DBMET00589 | |
| 0.39 | 0.117 | 0.561 | Caspase 9 stimulant | 0.561 0.042 DBMET00589 | DBMET00589 | |
| 0.277 | 0.005 | 0.277 | ABCA1 expression enhancer | |||
| 0.274 | 0.003 | 0.274 | Arachidonic acid antagonist | 0.22 0.017 DBMET00589 | ||
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | |||
| 0.262 | 0.003 | 0.262 | Glycine receptor agonist | 0.232 0.003 DBMET00589 | ||
| 0.268 | 0.011 | 0.268 | Ferrochelatase inhibitor | |||
| 0.26 | 0.003 | 0.26 | Bile acid receptor antagonist | 0.118 0.021 DBMET00589 | ||
| 0.3 | 0.045 | 0.3 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.26 | 0.009 | 0.26 | Adenylate kinase inhibitor | 0.152 0.026 DBMET00589 | ||
| 0.253 | 0.003 | 0.253 | Liver X receptor alpha agonist | |||
| 0.284 | 0.04 | 0.284 | Peroxidase inhibitor | |||
| 0.268 | 0.025 | 0.268 | Insulin sensitizer | 0.201 0.072 DBMET00589 | ||
| 0.245 | 0.004 | 0.245 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.052 DBMET00589 | ||
| 0.248 | 0.007 | 0.26 | Mucolytic | 0.26 0.005 DBMET00589 | DBMET00589 | |
| 0.252 | 0.011 | 0.252 | Farnesoid X receptor antagonist | 0.136 0.071 DBMET00589 | ||
| 0.247 | 0.007 | 0.337 | Triose-phosphate isomerase inhibitor | 0.337 0.004 DBMET00589 | DBMET00589 | |
| 0.247 | 0.008 | 0.247 | Alcohol dehydrogenase inhibitor | 0.109 0.043 DBMET00589 | ||
| 0.352 | 0.113 | 0.352 | 5 Hydroxytryptamine release inhibitor | 0.307 0.157 DBMET00589 | ||
| 0.29 | 0.055 | 0.551 | Antiamyloidogenic | 0.551 0.011 DBMET00589 | DBMET00589 | |
| 0.237 | 0.009 | 0.237 | Porphobilinogen synthase inhibitor | |||
| 0.307 | 0.078 | 0.485 | Immunomodulator | 0.485 0.025 DBMET00589 | DBMET00589 | |
| 0.254 | 0.027 | 0.485 | Amylase inhibitor | 0.485 0.006 DBMET00589 | DBMET00589 | |
| 0.233 | 0.015 | 0.515 | Expectorant | 0.515 0.004 DBMET00589 | DBMET00589 | |
| 0.234 | 0.016 | 0.249 | Mannose-6-phosphate isomerase inhibitor | 0.249 0.012 DBMET00589 | DBMET00589 | |
| 0.218 | 0.006 | 0.218 | Peroxisome proliferator-activated receptor gamma agonist | 0.064 0.055 DBMET00589 | ||
| 0.214 | 0.004 | 0.214 | Ornithine decarboxylase inhibitor | 0.128 0.021 DBMET00589 | ||
| 0.347 | 0.14 | 0.72 | Apoptosis agonist | 0.72 0.027 DBMET00589 | DBMET00589 | |
| 0.268 | 0.062 | 0.733 | Angiogenesis stimulant | 0.733 0.004 DBMET00589 | DBMET00589 | |
| 0.228 | 0.023 | 0.267 | Hexokinase inhibitor | 0.267 0.014 DBMET00589 | DBMET00589 | |
| 0.268 | 0.065 | 0.376 | Platelet antagonist | 0.376 0.032 DBMET00589 | DBMET00589 | |
| 0.223 | 0.019 | 0.297 | Cell adhesion inhibitor | 0.297 0.01 DBMET00589 | DBMET00589 | |
| 0.235 | 0.033 | 0.235 | Histone acetyltransferase inhibitor | |||
| 0.309 | 0.109 | 0.309 | Calpain 2 inhibitor | |||
| 0.231 | 0.032 | 0.372 | Interferon gamma antagonist | 0.372 0.012 DBMET00589 | DBMET00589 | |
| 0.212 | 0.013 | 0.212 | Catalase inhibitor | |||
| 0.246 | 0.052 | 0.246 | RNA-directed DNA polymerase inhibitor | 0.217 0.078 DBMET00589 | ||
| 0.198 | 0.004 | 0.198 | CXC chemokine 1 receptor antagonist | |||
| 0.201 | 0.009 | 0.212 | Cell adhesion molecule inhibitor | 0.212 0.009 DBMET00589 | DBMET00589 | |
| 0.286 | 0.095 | 0.434 | Apoptosis antagonist | 0.434 0.03 DBMET00589 | DBMET00589 | |
| 0.231 | 0.04 | 0.231 | Lipocortins synthesis antagonist | 0.167 0.084 DBMET00589 | ||
| 0.304 | 0.113 | 0.304 | GABA C receptor rho-3 antagonist | |||
| 0.202 | 0.012 | 0.202 | GABA C receptor antagonist | |||
| 0.243 | 0.054 | 0.508 | Nitric oxide antagonist | 0.508 0.015 DBMET00589 | DBMET00589 | |
| 0.192 | 0.004 | 0.192 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.191 | 0.008 | 0.191 | DOPA decarboxylase inhibitor | |||
| 0.193 | 0.017 | 0.193 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.18 0.019 DBMET00589 | ||
| 0.189 | 0.015 | 0.212 | Photosensitizer | 0.212 0.01 DBMET00589 | DBMET00589 | |
| 0.188 | 0.015 | 0.188 | Uric acid excretion stimulant | 0.188 0.015 DBMET00589 | ||
| 0.205 | 0.033 | 0.237 | Insulin secretagoues | 0.237 0.022 DBMET00589 | DBMET00589 | |
| 0.184 | 0.013 | 0.184 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.198 | 0.029 | 0.202 | DNA polymerase I inhibitor | 0.202 0.028 DBMET00589 | DBMET00589 | |
| 0.187 | 0.019 | 0.187 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.207 | 0.04 | 0.207 | Phospholipase C inhibitor | 0.17 0.073 DBMET00589 | ||
| 0.276 | 0.11 | 0.28 | Vasodilator, peripheral | 0.28 0.108 DBMET00589 | DBMET00589 | |
| 0.189 | 0.022 | 0.189 | Interleukin 1b antagonist | 0.098 0.083 DBMET00589 | ||
| 0.187 | 0.027 | 0.187 | 5-Lipoxygenase inhibitor | |||
| 0.179 | 0.019 | 0.179 | Pregnane X receptor agonist | |||
| 0.219 | 0.06 | 0.219 | Neurotrophic factor enhancer | 0.193 0.084 DBMET00589 | ||
| 0.188 | 0.029 | 0.188 | Toll-Like receptor 2 antagonist | |||
| 0.161 | 0.004 | 0.161 | Aconitate hydratase inhibitor | |||
| 0.186 | 0.029 | 0.186 | Adenylate cyclase inhibitor | 0.135 0.056 DBMET00589 | ||
| 0.161 | 0.004 | 0.161 | Liver X receptor beta agonist | |||
| 0.33 | 0.174 | 0.33 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.245 | 0.091 | 0.245 | 5 Hydroxytryptamine release stimulant | 0.182 0.138 DBMET00589 | ||
| 0.155 | 0.004 | 0.155 | GABA B receptor agonist | |||
| 0.159 | 0.009 | 0.159 | Leukotriene antagonist | 0.102 0.021 DBMET00589 | ||
| 0.256 | 0.106 | 0.256 | 12-Lipoxygenase inhibitor | |||
| 0.154 | 0.003 | 0.154 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.16 | 0.01 | 0.16 | Aldose reductase inhibitor | 0.073 0.026 DBMET00589 | ||
| 0.157 | 0.009 | 0.157 | Alcohol oxidase inhibitor | |||
| 0.167 | 0.021 | 0.167 | TRPA1 agonist | |||
| 0.17 | 0.023 | 0.17 | Vanilloid 1 agonist | 0.153 0.036 DBMET00589 | ||
| 0.164 | 0.017 | 0.164 | Prolactin inhibitor | |||
| 0.164 | 0.019 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 DBMET00589 | DBMET00589 | |
| 0.208 | 0.065 | 0.304 | DNA methyltransferase I inhibitor | 0.304 0.025 DBMET00589 | DBMET00589 | |
| 0.144 | 0.003 | 0.144 | Retinoid X alpha receptor agonist | |||
| 0.172 | 0.032 | 0.172 | Cystathionine beta-synthase inhibitor | |||
| 0.169 | 0.029 | 0.241 | Microtubule formation inhibitor | 0.241 0.011 DBMET00589 | DBMET00589 | |
| 0.146 | 0.007 | 0.146 | 5-Alpha-reductase inhibitor | |||
| 0.183 | 0.046 | 0.183 | Neurotensin receptor agonist | |||
| 0.208 | 0.074 | 0.36 | DNA methylase inhibitor | 0.36 0.015 DBMET00589 | DBMET00589 | |
| 0.148 | 0.013 | 0.148 | Glutamate decarboxylase inhibitor | |||
| 0.137 | 0.005 | 0.137 | Estrogen-related receptor beta agonist | |||
| 0.168 | 0.038 | 0.168 | Aldehyde dehydrogenase inhibitor | 0.11 0.083 DBMET00589 | ||
| 0.147 | 0.016 | 0.147 | Glutamate dehydrogenase inhibitor | 0.074 0.051 DBMET00589 | ||
| 0.201 | 0.071 | 0.201 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.154 0.139 DBMET00589 | ||
| 0.147 | 0.018 | 0.147 | Thioredoxin inhibitor | 0.137 0.021 DBMET00589 | ||
| 0.165 | 0.038 | 0.165 | Cholesterol synthesis inhibitor | 0.113 0.071 DBMET00589 | ||
| 0.158 | 0.03 | 0.158 | Nav1.1 sodium channel blocker | |||
| 0.168 | 0.041 | 0.462 | Monophenol monooxygenase inhibitor | 0.462 0.009 DBMET00589 | DBMET00589 | |
| 0.165 | 0.04 | 0.165 | Protein-tyrosine phosphatase 1B inhibitor | 0.155 0.043 DBMET00589 | ||
| 0.18 | 0.056 | 0.18 | Protein-tyrosine phosphatase inhibitor | 0.153 0.075 DBMET00589 | ||
| 0.136 | 0.014 | 0.15 | Glutamate release inhibitor | 0.15 0.01 DBMET00589 | DBMET00589 | |
| 0.141 | 0.02 | 0.212 | Phosphofructokinase-1 inhibitor | 0.212 0.01 DBMET00589 | DBMET00589 | |
| 0.156 | 0.035 | 0.156 | Aminopeptidase B inhibitor | |||
| 0.124 | 0.004 | 0.124 | DNA helicase inhibitor | 0.058 0.03 DBMET00589 | ||
| 0.183 | 0.063 | 0.183 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.122 | 0.004 | 0.122 | Urate transporter 1 inhibitor | |||
| 0.171 | 0.055 | 0.219 | Protein kinase stimulant | 0.219 0.035 DBMET00589 | DBMET00589 | |
| 0.132 | 0.016 | 0.132 | CDC25A inhibitor | 0.067 0.063 DBMET00589 | ||
| 0.12 | 0.005 | 0.12 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.161 | 0.046 | 0.161 | Adenylate cyclase stimulant | |||
| 0.156 | 0.041 | 0.156 | Antibacterial (Helicobacter pylori) | 0.145 0.051 DBMET00589 | ||
| 0.16 | 0.045 | 0.16 | MAP kinase kinase 4 inhibitor | |||
| 0.118 | 0.004 | 0.118 | Retinoid X receptor agonist | |||
| 0.169 | 0.06 | 0.225 | Melanin inhibitor | 0.225 0.033 DBMET00589 | DBMET00589 | |
| 0.142 | 0.033 | 0.248 | Mediator release inhibitor | 0.248 0.01 DBMET00589 | DBMET00589 | |
| 0.198 | 0.092 | 0.198 | Nitric-oxide synthase stimulant | 0.185 0.117 DBMET00589 | ||
| 0.183 | 0.077 | 0.433 | Hepatoprotectant | 0.433 0.011 DBMET00589 | DBMET00589 | |
| 0.134 | 0.032 | 0.134 | Creatine kinase inhibitor | |||
| 0.106 | 0.004 | 0.106 | Liver X receptor beta antagonist | |||
| 0.118 | 0.015 | 0.118 | Argininosuccinate synthase inhibitor | |||
| 0.121 | 0.019 | 0.121 | Aminopeptidase I inhibitor | |||
| 0.12 | 0.019 | 0.127 | ATPase (Vacuolar H+) inhibitor | 0.127 0.015 DBMET00589 | DBMET00589 | |
| 0.112 | 0.015 | 0.112 | Prostaglandin antagonist | |||
| 0.111 | 0.016 | 0.111 | Biliverdin reductase inhibitor | |||
| 0.096 | 0.002 | 0.096 | Retinoid X beta receptor antagonist | |||
| 0.113 | 0.019 | 0.113 | GABA aminotransferase inhibitor | 0.107 0.022 DBMET00589 | ||
| 0.1 | 0.006 | 0.1 | Thromboxane synthase inhibitor | |||
| 0.129 | 0.038 | 0.39 | UDP-glucose 4-epimerase inhibitor | 0.39 0.006 DBMET00589 | DBMET00589 | |
| 0.093 | 0.002 | 0.093 | Retinoid X receptor antagonist | |||
| 0.119 | 0.029 | 0.244 | NADH dehydrogenase inhibitor | 0.244 0.008 DBMET00589 | DBMET00589 | |
| 0.097 | 0.008 | 0.097 | MDM2 inhibitor | |||
| 0.114 | 0.026 | 0.114 | Glutathione S-transferase inhibitor | |||
| 0.258 | 0.17 | 0.626 | Antibacterial | 0.626 0.016 DBMET00589 | DBMET00589 | |
| 0.107 | 0.023 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.149 | 0.066 | 0.305 | Cell wall synthesis inhibitor | 0.305 0.01 DBMET00589 | DBMET00589 | |
| 0.13 | 0.047 | 0.13 | Caspase 3 inhibitor | |||
| 0.091 | 0.008 | 0.091 | Liver X receptor agonist | |||
| 0.22 | 0.138 | 0.22 | Thyroid hormone beta antagonist | |||
| 0.092 | 0.01 | 0.092 | CD45 antagonist | |||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | |||
| 0.09 | 0.01 | 0.09 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.082 | 0.002 | 0.082 | Retinoid X alpha receptor antagonist | |||
| 0.092 | 0.013 | 0.106 | Nitric oxide donor | 0.106 0.006 DBMET00589 | DBMET00589 | |
| 0.104 | 0.025 | 0.104 | Prostaglandin-E synthase inhibitor | |||
| 0.109 | 0.03 | 0.109 | Cathepsin G inhibitor | |||
| 0.092 | 0.014 | 0.092 | Thromboxane antagonist | |||
| 0.196 | 0.118 | 0.286 | DNA damaging | 0.286 0.063 DBMET00589 | DBMET00589 | |
| 0.084 | 0.006 | 0.084 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.174 | 0.097 | 0.194 | Psychostimulant | 0.194 0.084 DBMET00589 | DBMET00589 | |
| 0.177 | 0.101 | 0.177 | Anticonvulsant | |||
| 0.124 | 0.048 | 0.124 | Estrogen antagonist | |||
| 0.194 | 0.119 | 0.194 | Calpain inhibitor | |||
| 0.087 | 0.012 | 0.087 | NMDA receptor subunit 3B antagonist | |||
| 0.141 | 0.067 | 0.141 | Bone formation stimulant | 0.134 0.073 DBMET00589 | ||
| 0.08 | 0.006 | 0.08 | AMPA 4 receptor antagonist | |||
| 0.096 | 0.022 | 0.096 | Elastase 1 inhibitor | |||
| 0.1 | 0.026 | 0.1 | Leukotriene synthesis inhibitor | |||
| 0.089 | 0.016 | 0.101 | Transcription factor AP-1 inhibitor | 0.101 0.013 DBMET00589 | DBMET00589 | |
| 0.094 | 0.022 | 0.094 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.115 | 0.044 | 0.115 | Anabolic | |||
| 0.12 | 0.049 | 0.136 | Acetylcholine release stimulant | 0.136 0.027 DBMET00589 | DBMET00589 | |
| 0.079 | 0.008 | 0.079 | AICAR transformylase inhibitor | |||
| 0.136 | 0.066 | 0.136 | NADPH oxidase inhibitor | |||
| 0.128 | 0.059 | 0.128 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.114 | 0.045 | 0.114 | Folate antagonist | |||
| 0.077 | 0.008 | 0.077 | Cholesterol esterase inhibitor | 0.045 0.038 DBMET00589 | ||
| 0.112 | 0.043 | 0.112 | Estrogen receptor beta antagonist | |||
| 0.097 | 0.029 | 0.097 | Estrogen receptor alpha antagonist | |||
| 0.111 | 0.044 | 0.111 | Electrolyte absorption antagonist | |||
| 0.087 | 0.02 | 0.087 | Glutamate (mGluR7) antagonist | |||
| 0.102 | 0.035 | 0.102 | Inducible nitric-oxide synthase inhibitor | |||
| 0.085 | 0.019 | 0.085 | Exportin-1 inhibitor | |||
| 0.078 | 0.013 | 0.078 | Leukocyte elastase inhibitor | |||
| 0.077 | 0.012 | 0.077 | Dihydroorotate oxidase inhibitor | |||
| 0.07 | 0.006 | 0.07 | 5-Alpha-reductase 2 inhibitor | |||
| 0.096 | 0.033 | 0.096 | Keratolytic | |||
| 0.162 | 0.099 | 0.221 | P-glycoprotein inhibitor | 0.221 0.052 DBMET00589 | DBMET00589 | |
| 0.086 | 0.023 | 0.086 | CDC25B inhibitor | 0.061 0.049 DBMET00589 | ||
| 0.074 | 0.013 | 0.074 | NMDA receptor subunit 3A antagonist | |||
| 0.077 | 0.016 | 0.077 | Thromboxane A2 antagonist | |||
| 0.064 | 0.004 | 0.064 | Thyroid hormone agonist | |||
| 0.071 | 0.012 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 DBMET00589 | DBMET00589 | |
| 0.068 | 0.009 | 0.068 | Fumarate hydratase inhibitor | |||
| 0.076 | 0.017 | 0.076 | Leukotriene B4 antagonist | 0.076 0.017 DBMET00589 | ||
| 0.067 | 0.01 | 0.067 | Glutamate (mGluR group III) antagonist | |||
| 0.072 | 0.015 | 0.072 | Oleamide hydrolase inhibitor | |||
| 0.084 | 0.027 | 0.084 | NMDA receptor agonist | |||
| 0.138 | 0.082 | 0.138 | Heat shock protein 70 antagonist | |||
| 0.12 | 0.065 | 0.12 | Proteasome inhibitor | |||
| 0.06 | 0.005 | 0.06 | Free fatty acid receptor 1 antagonist | |||
| 0.105 | 0.051 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.184 | 0.13 | 0.471 | Immunostimulant | 0.471 0.033 DBMET00589 | DBMET00589 | |
| 0.094 | 0.041 | 0.094 | Vanilloid agonist | |||
| 0.077 | 0.023 | 0.077 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.091 | 0.04 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.018 DBMET00589 | DBMET00589 | |
| 0.104 | 0.053 | 0.104 | Glutamate (mGluR7) agonist | |||
| 0.094 | 0.044 | 0.094 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.082 | 0.032 | 0.082 | Phospholipase D inhibitor | |||
| 0.065 | 0.016 | 0.065 | Macrophage elastase inhibitor | |||
| 0.056 | 0.007 | 0.056 | 5-Alpha-reductase 1 inhibitor | |||
| 0.189 | 0.14 | 0.299 | DNA synthesis inhibitor | 0.299 0.044 DBMET00589 | DBMET00589 | |
| 0.062 | 0.013 | 0.062 | Glutamate (mGluR4) antagonist | |||
| 0.054 | 0.005 | 0.054 | Cholesterol ester transfer protein antagonist | |||
| 0.086 | 0.038 | 0.086 | Histidine decarboxylase inhibitor | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR3) antagonist | |||
| 0.083 | 0.036 | 0.083 | HIV-1 integrase inhibitor | |||
| 0.066 | 0.018 | 0.066 | Leukotriene C antagonist | |||
| 0.117 | 0.069 | 0.117 | Anesthetic local | |||
| 0.088 | 0.041 | 0.101 | T cell inhibitor | 0.101 0.023 DBMET00589 | DBMET00589 | |
| 0.071 | 0.024 | 0.071 | Acetyl-CoA transferase inhibitor | |||
| 0.068 | 0.023 | 0.068 | Elastase inhibitor | |||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | |||
| 0.049 | 0.005 | 0.049 | Elastase 2B inhibitor | 0.031 0.02 DBMET00589 | ||
| 0.049 | 0.005 | 0.049 | Elastase 3B inhibitor | 0.031 0.02 DBMET00589 | ||
| 0.049 | 0.005 | 0.049 | Elastase 3A inhibitor | 0.031 0.02 DBMET00589 | ||
| 0.083 | 0.04 | 0.083 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.053 | 0.01 | 0.053 | Glutamate (mGluR8) agonist | |||
| 0.101 | 0.059 | 0.101 | Nitric-oxide synthase inhibitor | |||
| 0.072 | 0.03 | 0.072 | Purinergic P2X1 antagonist | |||
| 0.053 | 0.012 | 0.053 | p53 inhibitor | |||
| 0.047 | 0.006 | 0.047 | Liver X receptor alpha antagonist | |||
| 0.045 | 0.004 | 0.045 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET00589 | ||
| 0.098 | 0.058 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.086 | 0.046 | 0.086 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.049 | 0.01 | 0.049 | Liver X receptor antagonist | |||
| 0.199 | 0.16 | 0.199 | Nootropic | |||
| 0.058 | 0.02 | 0.058 | Carbonic anhydrase IV inhibitor | |||
| 0.097 | 0.058 | 0.097 | Potassium channel (Ca-activated) activator | |||
| 0.046 | 0.008 | 0.046 | Lysine carboxypeptidase inhibitor | |||
| 0.071 | 0.034 | 0.071 | Aromatase inhibitor | |||
| 0.044 | 0.007 | 0.044 | Prostaglandin D2 antagonist | |||
| 0.044 | 0.008 | 0.044 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.071 | 0.036 | 0.071 | NMDA receptor glycine site agonist | |||
| 0.098 | 0.064 | 0.098 | GABA C receptor rho-1 antagonist | |||
| 0.059 | 0.025 | 0.129 | Glucose-6-phosphate translocase inhibitor | 0.129 0.004 DBMET00589 | DBMET00589 | |
| 0.041 | 0.009 | 0.041 | Glutamate (mGluR3) agonist | |||
| 0.139 | 0.107 | 0.139 | Antipruritic | |||
| 0.128 | 0.096 | 0.148 | Diuretic | 0.148 0.079 DBMET00589 | DBMET00589 | |
| 0.044 | 0.013 | 0.044 | AMPA receptor agonist | |||
| 0.07 | 0.04 | 0.07 | Neutrophil collagenase inhibitor | |||
| 0.085 | 0.055 | 0.085 | D-Ala-D-Ala ligase inhibitor | |||
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | 0.043 0.028 DBMET00589 | ||
| 0.062 | 0.033 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.065 0.03 DBMET00589 | DBMET00589 | |
| 0.047 | 0.019 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.058 | 0.031 | 0.058 | NMDA 2A receptor antagonist | |||
| 0.108 | 0.08 | 0.216 | Alkylator | 0.216 0.022 DBMET00589 | DBMET00589 | |
| 0.059 | 0.032 | 0.059 | Ornithine carbamoyltransferase inhibitor | |||
| 0.041 | 0.013 | 0.041 | Melatonin receptor 1A agonist | |||
| 0.044 | 0.017 | 0.044 | Leukotriene C4 antagonist | |||
| 0.036 | 0.009 | 0.036 | CXC chemokine 2 receptor antagonist | |||
| 0.071 | 0.045 | 0.071 | Purinergic P2X2 antagonist | |||
| 0.056 | 0.03 | 0.114 | Heparanase inhibitor | 0.114 0.003 DBMET00589 | DBMET00589 | |
| 0.039 | 0.014 | 0.039 | Carboxypeptidase B inhibitor | |||
| 0.041 | 0.015 | 0.041 | Glutamate (mGluR8) antagonist | |||
| 0.043 | 0.017 | 0.043 | Integrin alpha2 antagonist | |||
| 0.034 | 0.009 | 0.034 | Prostaglandin H2 antagonist | |||
| 0.028 | 0.003 | 0.028 | Thyroid hormone beta agonist | |||
| 0.046 | 0.022 | 0.046 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.078 | 0.054 | 0.078 | Metalloproteinase-2 inhibitor | |||
| 0.038 | 0.014 | 0.038 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.029 | 0.006 | 0.029 | Free fatty acid receptor 1 agonist | |||
| 0.038 | 0.015 | 0.038 | ATP citrate lysase inhibitor | |||
| 0.129 | 0.106 | 0.129 | GABA C receptor rho-2 antagonist | |||
| 0.039 | 0.016 | 0.039 | HMG CoA reductase inhibitor | |||
| 0.099 | 0.077 | 0.099 | Nav1.4 sodium channel blocker | |||
| 0.031 | 0.01 | 0.031 | Retinoid X gamma receptor agonist | |||
| 0.063 | 0.042 | 0.063 | Caspase 9 inhibitor | |||
| 0.055 | 0.034 | 0.055 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.143 | 0.122 | 0.143 | Pyruvate kinase inhibitor | |||
| 0.041 | 0.02 | 0.041 | Nicotinic acid receptor agonist | |||
| 0.024 | 0.003 | 0.024 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.039 | 0.019 | 0.039 | Prostacyclin antagonist | |||
| 0.028 | 0.008 | 0.028 | Retinoic acid alpha receptor antagonist | |||
| 0.025 | 0.005 | 0.025 | Thyroid hormone alpha antagonist | |||
| 0.024 | 0.005 | 0.024 | Thyroid hormone alpha agonist | |||
| 0.042 | 0.023 | 0.042 | Membrane dipeptidase inhibitor | |||
| 0.023 | 0.004 | 0.023 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.11 | 0.091 | 0.11 | Tubulin antagonist | |||
| 0.059 | 0.041 | 0.059 | Ryanodine receptor antagonist | |||
| 0.046 | 0.029 | 0.046 | Integrin antagonist | |||
| 0.036 | 0.019 | 0.036 | Estrogen-related receptor alpha antagonist | |||
| 0.138 | 0.121 | 0.47 | Platelet adhesion inhibitor | 0.47 0.006 DBMET00589 | DBMET00589 | |
| 0.059 | 0.042 | 0.059 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.051 | 0.034 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.054 | 0.039 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.049 | 0.034 | 0.049 | Plasminogen activator inhibitor antagonist | |||
| 0.026 | 0.012 | 0.026 | Prostaglandin F2 alpha agonist | |||
| 0.06 | 0.046 | 0.06 | Prostaglandin F2 alpha antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoic acid receptor antagonist | |||
| 0.032 | 0.018 | 0.032 | Glucagon receptor antagonist | |||
| 0.049 | 0.035 | 0.049 | Bombesin 2 receptor antagonist | |||
| 0.04 | 0.026 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.024 | 0.012 | 0.024 | Retinoid X beta receptor agonist | |||
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.062 | 0.05 | 0.062 | Calcium channel P-type blocker | |||
| 0.027 | 0.016 | 0.027 | Integrin alpha2beta1 antagonist | |||
| 0.029 | 0.018 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.041 | 0.031 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.02 | 0.009 | 0.02 | CXC chemokine 5 receptor antagonist | |||
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.04 | 0.03 | 0.04 | Integrin alpha5beta1 antagonist | |||
| 0.038 | 0.028 | 0.038 | MAP3K5 inhibitor | |||
| 0.055 | 0.045 | 0.055 | Pregnane X receptor antagonist | |||
| 0.03 | 0.021 | 0.03 | Factor VII inhibitor | |||
| 0.074 | 0.065 | 0.074 | Carbonic anhydrase VI inhibitor | |||
| 0.112 | 0.103 | 0.362 | Lipid peroxidase inhibitor | 0.362 0.012 DBMET00589 | DBMET00589 | |
| 0.055 | 0.047 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.023 | 0.015 | 0.023 | ICAM 1 antagonist | |||
| 0.055 | 0.047 | 0.055 | Carbonic anhydrase stimulant | |||
| 0.038 | 0.031 | 0.038 | Dopamine D5 agonist | |||
| 0.017 | 0.009 | 0.017 | Calcium-sensing receptor antagonist | |||
| 0.024 | 0.017 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.093 | 0.086 | 0.093 | GABA receptor agonist | |||
| 0.018 | 0.011 | 0.018 | G-protein-coupled receptor 120 agonist | |||
| 0.049 | 0.042 | 0.049 | Alpha tubulin antagonist | |||
| 0.015 | 0.009 | 0.015 | Integrin beta6 antagonist | |||
| 0.017 | 0.011 | 0.018 | Vitamin D receptor agonist | 0.018 0.009 DBMET00589 | DBMET00589 | |
| 0.021 | 0.016 | 0.021 | Integrin alphaVbeta3 antagonist | |||
| 0.052 | 0.048 | 0.099 | Adenine nucleotide translocase inhibitor | 0.099 0.005 DBMET00589 | DBMET00589 | |
| 0.022 | 0.017 | 0.022 | Retinoic acid gamma receptor agonist | |||
| 0.087 | 0.082 | 0.087 | Urease inhibitor | |||
| 0.024 | 0.02 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DBMET00589 | DBMET00589 | |
| 0.036 | 0.033 | 0.036 | GABA uptake inhibitor | |||
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.057 | 0.054 | 0.057 | Heme oxygenase stimulant | |||
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.011 | 0.008 | 0.011 | Thromboxane agonist | |||
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.02 | 0.017 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.025 | 0.022 | 0.025 | Nicotinic acid receptor 2 antagonist | |||
| 0.152 | 0.149 | 0.199 | Cyclic AMP phosphodiesterase inhibitor | 0.199 0.095 DBMET00589 | DBMET00589 | |
| 0.03 | 0.028 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.023 | 0.021 | 0.023 | Leukotriene D4 antagonist | |||
| 0.031 | 0.029 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid receptor gamma antagonist | |||
| 0.02 | 0.02 | 0.024 | Vitamin D receptor antagonist | 0.024 0.012 DBMET00589 | DBMET00589 | |
| 0.048 | 0.049 | 0.078 | Alpha-mannosidase inhibitor | 0.078 0.012 DBMET00589 | DBMET00589 | |
| 0.015 | 0.017 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET00589 | DBMET00589 | |
| 0.071 | 0.073 | 0.096 | Glycine receptor antagonist | 0.096 0.036 DBMET00589 | DBMET00589 | |
| 0.082 | 0.087 | 0.114 | Xanthine oxidase inhibitor | 0.114 0.051 DBMET00589 | DBMET00589 | |
| 0.013 | 0.018 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 DBMET00589 | DBMET00589 | |
| 0.016 | 0.024 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 DBMET00589 | DBMET00589 | |
| 0.111 | 0.124 | 0.214 | Anticoagulant | 0.214 0.048 DBMET00589 | DBMET00589 | |
| 0.034 | 0.05 | 0.047 | Estrogen agonist | 0.047 0.037 DBMET00589 | DBMET00589 | |
| 0.035 | 0.052 | 0.072 | Mannosidase inhibitor | 0.072 0.011 DBMET00589 | DBMET00589 | |
| 0.097 | 0.124 | 0.153 | Interleukin 4 antagonist | 0.153 0.047 DBMET00589 | DBMET00589 | |
| 0.017 | 0.047 | 0.079 | Sodium/glucose cotransporter 2 inhibitor | 0.079 0.004 DBMET00589 | DBMET00589 | |
| 0.018 | 0.052 | 0.067 | Sodium/glucose cotransporter inhibitor | 0.067 0.004 DBMET00589 | DBMET00589 | |
| 0.048 | 0.085 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 DBMET00589 | DBMET00589 | |
| 0.04 | 0.08 | 0.048 | Factor III inhibitor | 0.048 0.041 DBMET00589 | DBMET00589 | |
| 0.081 | 0.121 | 0.206 | Beta amyloid protein antagonist | 0.206 0.015 DBMET00589 | DBMET00589 | |
| 0.035 | 0.081 | 0.101 | Factor IXa inhibitor | 0.101 0.009 DBMET00589 | DBMET00589 | |
| 0.029 | 0.076 | 0.058 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 DBMET00589 | DBMET00589 | |
| 0.035 | 0.085 | 0.05 | Protein kinase C eta inhibitor | 0.05 0.044 DBMET00589 | DBMET00589 | |
| 0.01 | 0.064 | 0.034 | Squalene synthetase inhibitor | 0.034 0.021 DBMET00589 | DBMET00589 | |
| 0.01 | 0.066 | 0.021 | Corticosteroid-like | 0.021 0.016 DBMET00589 | DBMET00589 | |
| 0.028 | 0.086 | 0.099 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 DBMET00589 | DBMET00589 | |
| 0.103 | 0.161 | 0.273 | Hemostatic | 0.273 0.019 DBMET00589 | DBMET00589 | |
| 0.146 | 0.206 | 0.359 | Peptidyltransferase inhibitor | 0.359 0.011 DBMET00589 | DBMET00589 | |
| 0.024 | 0.087 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.025 DBMET00589 | DBMET00589 | |
| 0.018 | 0.083 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET00589 | DBMET00589 | |
| 0.002 | 0.071 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET00589 | DBMET00589 | |
| 0.068 | 0.145 | 0.177 | AMP-activated protein kinase stimulant | 0.177 0.015 DBMET00589 | DBMET00589 | |
| 0.03 | 0.126 | 0.201 | Antineoplastic antibiotic | 0.201 0.021 DBMET00589 | DBMET00589 | |
| 0.068 | 0.166 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.06 DBMET00589 | DBMET00589 | |
| 0.156 | 0.258 | 0.235 | Caspase 3 stimulant | 0.235 0.126 DBMET00589 | DBMET00589 | |
| 0.087 | 0.191 | 0.167 | DNA repair enzyme inhibitor | 0.167 0.019 DBMET00589 | DBMET00589 | |
| 0.025 | 0.134 | 0.353 | Selectin antagonist | 0.353 0.004 DBMET00589 | DBMET00589 | |
| 0.023 | 0.135 | 0.052 | Microtubule stabilization | 0.052 0.026 DBMET00589 | DBMET00589 | |
| 0.057 | 0.186 | 0.191 | Beta glucuronidase inhibitor | 0.191 0.014 DBMET00589 | DBMET00589 | |
| 0.02 | 0.153 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 DBMET00589 | DBMET00589 | |
| 0.06 | 0.195 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 DBMET00589 | DBMET00589 | |
| 0.072 | 0.273 | 0.243 | NOS3 expression enhancer | 0.243 0.028 DBMET00589 | DBMET00589 | |
| 0.11 | 0.314 | 0.401 | Alpha-glucosidase inhibitor | 0.401 0.114 DBMET00589 | DBMET00589 | |
| 0.02 | 0.244 | 0.072 | Neuraminidase (influenza) inhibitor | 0.072 0.032 DBMET00589 | DBMET00589 | |
| 0.012 | 0.254 | 0.06 | Neuraminidase inhibitor | 0.06 0.044 DBMET00589 | DBMET00589 | |
| 0.021 | 0.293 | 0.081 | Topoisomerase II alpha inhibitor | 0.081 0.053 DBMET00589 | DBMET00589 | |
| 0.042 | 0.33 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 DBMET00589 | DBMET00589 | |
| 0.043 | 0.44 | 0.282 | Vasodilator | 0.282 0.055 DBMET00589 | DBMET00589 | |
| 0.017 | 0.416 | 0.226 | Topoisomerase I inhibitor | 0.226 0.021 DBMET00589 | DBMET00589 | |
| 0.024 | 0.435 | 0.13 | Multidrug resistance-associated protein 1 inhibitor | 0.13 0.038 DBMET00589 | DBMET00589 | |
| 0.016 | 0.466 | 0.112 | Topoisomerase II inhibitor | 0.112 0.074 DBMET00589 | DBMET00589 | |
| 0.012 | 0.478 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 DBMET00589 | DBMET00589 | |
| 0.036 | 0.504 | 0.394 | Tumour necrosis factor alpha release inhibitor | 0.394 0.028 DBMET00589 | DBMET00589 | |
| 0.045 | 0.515 | 0.228 | Angiogenesis inhibitor | 0.228 0.14 DBMET00589 | DBMET00589 | |
| 0.073 | 0.634 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.054 DBMET00589 | DBMET00589 | |
| 0.004 | 0.582 | 0.033 | Protein 30S ribosomal subunit inhibitor | 0.033 0.012 DBMET00589 | DBMET00589 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |